Robert W.A. Sellers - Feb 12, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Feb 12, 2024
Transactions value $
-$613,553
Form type
4
Date filed
2/12/2024, 05:44 PM
Previous filing
May 15, 2023
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $449K +12.2K +93.3% $36.75 25.3K Feb 12, 2024 Direct
transaction EW Common Stock Sale -$1.06M -12.2K -48.27% $87.00 13.1K Feb 12, 2024 Direct
holding EW Common Stock 20.4K Feb 12, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -12.2K -100% $0.00* 0 Feb 12, 2024 Common Stock 12.2K $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.